PL362838A1 - Antagoniści somatostatyny - Google Patents

Antagoniści somatostatyny

Info

Publication number: PL362838A1
Authority: PL; Poland
Prior art keywords: somatostatin antagonists; somatostatin; antagonists
Prior art date: 2001-03-08

Application number

PL02362838A

Other languages

English (en)

Inventor

David H. Coy

William A. Murphy

Walajapet G. Rajeswaran

Original Assignee

The Administrators Of The Tulane Educational Fund

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-08

Filing date

2002-03-05

Publication date

2004-11-02

2002-03-05 Application filed by The Administrators Of The Tulane Educational Fund filed Critical The Administrators Of The Tulane Educational Fund

2004-11-02 Publication of PL362838A1 publication Critical patent/PL362838A1/pl

Links

102000005157 Somatostatin Human genes 0.000 title 1
108010056088 Somatostatin Proteins 0.000 title 1
239000005557 antagonist Substances 0.000 title 1
NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 title 1
229960000553 somatostatin Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Zoology (AREA)
Hematology (AREA)
Biophysics (AREA)
Toxicology (AREA)
Molecular Biology (AREA)
Obesity (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Cardiology (AREA)
Emergency Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Dermatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL02362838A 2001-03-08 2002-03-05 Antagoniści somatostatyny PL362838A1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US27430801P	2001-03-08	2001-03-08
PCT/US2002/006676 WO2002072602A2 (en)	2001-03-08	2002-03-05	Somatostatin antagonists

Publications (1)

Publication Number	Publication Date
PL362838A1 true PL362838A1 (pl)	2004-11-02

Family

ID=23047655

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL02362838A PL362838A1 (pl)	2001-03-08	2002-03-05	Antagoniści somatostatyny

Country Status (16)

Country	Link
US (3)	US7378488B2 (pl)
EP (1)	EP1372688B1 (pl)
JP (3)	JP4204322B2 (pl)
AR (1)	AR035942A1 (pl)
AT (1)	ATE394114T1 (pl)
AU (1)	AU2002258465B2 (pl)
CA (1)	CA2439498A1 (pl)
CZ (1)	CZ299362B6 (pl)
DE (1)	DE60226419D1 (pl)
DK (1)	DK1372688T3 (pl)
ES (1)	ES2306766T3 (pl)
HU (1)	HUP0401535A3 (pl)
NO (1)	NO20033911L (pl)
PL (1)	PL362838A1 (pl)
RU (2)	RU2263678C2 (pl)
WO (1)	WO2002072602A2 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1355940T3 (da) *	2000-10-20	2008-01-07	Univ Tulane	Urotensin II-agonister og -antagonister
DK1372688T3 (da)	2001-03-08	2008-08-25	Univ Tulane	Somatostatin-antagonister
RU2259375C2 (ru) *	2001-04-09	2005-08-27	Дзе Администрейторс Оф Дзе Тьюлейн Эдьюкейшнл Фанд	Агонисты соматостатина
EP1522311A1 (fr)	2003-10-10	2005-04-13	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Utilisation de la somatostine ou d'un de ses analogues pour préparer un médicament destiné à réguler la réserve folliculaire ovarienne chez la femme non ménopausée
US8017575B2 (en) *	2004-12-15	2011-09-13	Wilfred Wayne Lautt	Treatment of insulin resistance by modulating somatostatin using somatostatin receptor antagonists
US8691761B2 (en)	2006-10-16	2014-04-08	Jean E. F. Rivier	Somatostatin receptor 2 antagonists
PL2076535T3 (pl)	2006-10-16	2013-08-30	Salk Inst Biological Studies	Antagoniści somatostatyny selektywni względem receptora (SSTR2)
EP2168983A1 (fr)	2008-09-30	2010-03-31	Ipsen Pharma	Nouveaux composés octapeptidiques et leur utilisation thérapeutique
US9464306B2 (en)	2008-10-29	2016-10-11	Kaneka Corporation	Method for producing L-amino acid
EP2399931A1 (fr) *	2010-06-22	2011-12-28	Ipsen Pharma S.A.S.	Nouveaux composés octapeptidiques et leur utilisation thérapeutique
WO2017136943A1 (en) *	2016-02-09	2017-08-17	Cdrd Ventures Inc.	Somatostatin receptor antagonist compounds and methods of using the same
WO2021111503A1 (ja) *	2019-12-02	2021-06-10	花王株式会社	光吸収層及びその製造方法、分散液、光電変換素子、並びに太陽電池

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE43335T1 (de) *	1980-02-14	1989-06-15	Sandoz Ag	Peptide die einen (1s,2r,3r)- oder (1r,2s,3s)-1nitrilo-1-carbonyl-3-methyl-2-oxyheptan oder hept-5-en-rest enthalten brauchbar in totaler synsthese von cyclosporinen, und verfahren zu ihrer herstellung.
JPS63146850A (ja)	1986-11-12	1988-06-18	メルク　エンド　カムパニー　インコーポレーテツド	フエニルアラニル−ヒスチジン代用成分を有するレニン阻害剤
EP0278158A3 (en)	1986-11-12	1990-05-23	Merck & Co. Inc.	Renin inhibitors containing phenylalanyl-histidine replacements
EP0273696A2 (en)	1987-01-02	1988-07-06	Merck & Co. Inc.	Renin inhibitors containing histidine replacements
CH679045A5 (pl)	1987-06-29	1991-12-13	Sandoz Ag
JPS6426599U (pl)	1987-08-10	1989-02-15
DE68928278T2 (de)	1988-02-10	1998-03-12	Tap Pharmaceuticals Inc	Lhrh-analog
DE69027767T2 (de) *	1989-12-08	1997-01-02	Univ Tulane	Oktapeptidanaloge von somatostatin mit threonin in position 6
US7223833B1 (en) *	1991-05-24	2007-05-29	Isis Pharmaceuticals, Inc.	Peptide nucleic acid conjugates
WO1993003058A2 (en)	1991-07-01	1993-02-18	University Technologies International Inc.	NON-DESENSITIZING ANALOGS OF GnRH AND OTHER BIOLOGICALLY ACTIVE LIGANDS
JP3480848B2 (ja) *	1992-06-19	2003-12-22	タカラバイオ株式会社	環状ペプチドの合成方法
US5569741A (en) *	1992-07-27	1996-10-29	Biomeasure, Inc.	Cyclic octapeptide neuromedin B receptor antagonists
SI9420051A (en) *	1993-08-09	1996-12-31	Biomeasure Inc	Chemical modified peptide derivatives, process for their preparation and their use in human therapy
EP0736038B1 (en) *	1993-12-23	2001-07-04	Novo Nordisk A/S	Compounds with growth hormone releasing properties
GB9402767D0 (en)	1994-02-14	1994-04-06	Sandoz Ltd	Improvements in or relating to organic compounds
US5696230A (en) *	1994-08-31	1997-12-09	The Board Of Regents Of The University Of Nebraska	High-affinity response-selective C-terminal analogs of C5a anaphylatoxin
US5750499A (en) *	1995-10-18	1998-05-12	The Salk Institute For Biological Studies	Receptor-selective somatostatin analogs
US5846934A (en) *	1996-02-20	1998-12-08	American Cyanamid Company	Pure somatostatin antagonist and methods of use thereof
US6355613B1 (en) *	1996-07-31	2002-03-12	Peptor Limited	Conformationally constrained backbone cyclized somatostatin analogs
WO1998008528A1 (en)	1996-08-30	1998-03-05	Biomeasure Incorporated	Method of inhibiting fibrosis with a somatostatin agonist
AU4133997A (en) *	1996-09-12	1998-04-02	Yarom Cohen	Pharmaceutical composition for the treatment of syndrome x of reaven
PL334089A1 (en) *	1996-12-04	2000-01-31	Sod Conseils Rech Applic	Compounds antagonistic in respect to somatostatin
US6887470B1 (en) *	1999-09-10	2005-05-03	Conjuchem, Inc.	Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
EP1813625B1 (en) *	2001-03-06	2009-04-29	Il Consorzio Ferrara Richerche	Method of modulating the profileration of medullary thyroid carcinoma cells
DK1372688T3 (da)	2001-03-08	2008-08-25	Univ Tulane	Somatostatin-antagonister
RU2259375C2 (ru)	2001-04-09	2005-08-27	Дзе Администрейторс Оф Дзе Тьюлейн Эдьюкейшнл Фанд	Агонисты соматостатина

2002
- 2002-03-05 DK DK02728410T patent/DK1372688T3/da active
- 2002-03-05 AT AT02728410T patent/ATE394114T1/de not_active IP Right Cessation
- 2002-03-05 EP EP02728410A patent/EP1372688B1/en not_active Expired - Lifetime
- 2002-03-05 CA CA002439498A patent/CA2439498A1/en not_active Abandoned
- 2002-03-05 CZ CZ20032281A patent/CZ299362B6/cs not_active IP Right Cessation
- 2002-03-05 DE DE60226419T patent/DE60226419D1/de not_active Expired - Lifetime
- 2002-03-05 HU HU0401535A patent/HUP0401535A3/hu unknown
- 2002-03-05 PL PL02362838A patent/PL362838A1/pl not_active Application Discontinuation
- 2002-03-05 JP JP2002571515A patent/JP4204322B2/ja not_active Expired - Fee Related
- 2002-03-05 WO PCT/US2002/006676 patent/WO2002072602A2/en not_active Ceased
- 2002-03-05 AU AU2002258465A patent/AU2002258465B2/en not_active Ceased
- 2002-03-05 RU RU2003129807/04A patent/RU2263678C2/ru not_active IP Right Cessation
- 2002-03-05 ES ES02728410T patent/ES2306766T3/es not_active Expired - Lifetime
- 2002-03-05 US US10/469,836 patent/US7378488B2/en not_active Expired - Lifetime
- 2002-03-05 RU RU2005117614/04A patent/RU2328504C2/ru not_active IP Right Cessation
- 2002-03-07 AR ARP020100831A patent/AR035942A1/es not_active Application Discontinuation
2003
- 2003-09-04 NO NO20033911A patent/NO20033911L/no not_active Application Discontinuation
2006
- 2006-07-05 JP JP2006185373A patent/JP2006342171A/ja active Pending
2007
- 2007-08-20 US US11/894,231 patent/US7408024B2/en not_active Expired - Lifetime
2008
- 2008-03-11 US US12/075,319 patent/US20080171853A1/en not_active Abandoned
- 2008-05-12 JP JP2008124961A patent/JP2008255120A/ja active Pending

Also Published As

Publication number	Publication date
HUP0401535A3 (en)	2009-07-28
JP2008255120A (ja)	2008-10-23
US7378488B2 (en)	2008-05-27
EP1372688A2 (en)	2004-01-02
NO20033911L (no)	2003-10-29
DK1372688T3 (da)	2008-08-25
US20080171853A1 (en)	2008-07-17
EP1372688B1 (en)	2008-05-07
CZ20032281A3 (cs)	2004-01-14
RU2263678C2 (ru)	2005-11-10
US20040181032A1 (en)	2004-09-16
HUP0401535A2 (hu)	2004-12-28
JP4204322B2 (ja)	2009-01-07
RU2328504C2 (ru)	2008-07-10
AR035942A1 (es)	2004-07-28
NO20033911D0 (no)	2003-09-04
WO2002072602A3 (en)	2003-03-20
CA2439498A1 (en)	2002-09-19
DE60226419D1 (de)	2008-06-19
JP2004532824A (ja)	2004-10-28
ATE394114T1 (de)	2008-05-15
US7408024B2 (en)	2008-08-05
AU2002258465B2 (en)	2006-01-19
CZ299362B6 (cs)	2008-07-02
WO2002072602A2 (en)	2002-09-19
ES2306766T3 (es)	2008-11-16
US20080020970A1 (en)	2008-01-24
RU2003129807A (ru)	2005-03-20
EP1372688A4 (en)	2006-06-14
JP2006342171A (ja)	2006-12-21
RU2005117614A (ru)	2006-11-20

Legal Events

Date	Code	Title	Description
2010-08-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
IL165841A0 (en)	2006-01-15	Mchir antagonists
CA97154S (en)	2002-03-22	Drill
AU2002341834A1 (en)	2003-04-07	Antagonists
SI1671949T1 (sl)	2008-10-31	Substituirani pridinilamini
HU0101106D0 (en)	2001-05-28	Id alsorithm
CA97153S (en)	2002-03-22	Drill
IL158051A0 (en)	2004-03-28	Somatostatin agonists
PL362643A1 (pl)	2004-11-02	Podstawione fluoroalkoksyfenylosulfonylomoczniki
PL362838A1 (pl)	2004-11-02	Antagoniści somatostatyny
PL368050A1 (pl)	2005-03-21	Podstawione 4-aminocykloheksanole
GB0104554D0 (en)	2001-04-11	New uses
IL153176A0 (en)	2003-06-24	New phenylpiperazines
GB0112342D0 (en)	2001-07-11	Polypeptides
PL364601A1 (pl)	2004-12-13	Podstawione związki benzoheterocykliczne zawierające azot
PL364090A1 (pl)	2004-12-13	Nowe benzyloaminopirymidyny
GB0125051D0 (en)	2001-12-12	GT speedlock
GB0124684D0 (en)	2001-12-05	Tile
CA94144S (en)	2001-12-14	Drill
CA93112S (en)	2001-07-31	Drill
GB0006860D0 (en)	2000-05-10	Antagonists
GB0009125D0 (en)	2000-05-31	Antagonists
GB0120289D0 (en)	2001-10-17	V place
GB0127164D0 (en)	2002-01-02	Micro-pin interface
GB0217477D0 (en)	2002-09-04	Tiles
GB0104937D0 (en)	2001-04-18	Improved wells